Answer
Neither ketoconazole, a CYP3A4 and P-glycoprotein inhibitor, nor rifampicin, a CYP3A4 inducer, affected eribulin mesylate exposure measured by AUC and Cmax.
Sources for this answer
- Eribulin Eisai 0.44 mg/ml solution for injectionEisai Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 26Document updated
Sources checked